nafarelin has been researched along with Adenocarcinoma* in 1 studies
1 other study(ies) available for nafarelin and Adenocarcinoma
| Article | Year |
|---|---|
Treatment of stage D2 prostatic carcinoma with combined gonadal and adrenal suppression in a 60-year-old man.
A 60-year-old man with stage D2 prostatic carcinoma received treatment with a new luteinizing hormone-releasing hormone superagonist. After a seven-month remission; relapse of the disease occurred and an adrenal-suppressing dose of dexamethasone was added. The resulting combined gonadal and adrenal suppression led to another remission that lasted five months. This case supports other observations of the importance of adrenal androgen production in the pathobiology of prostatic carcinoma. Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Dexamethasone; Gonadotropin-Releasing Hormone; Humans; Lymphatic Metastasis; Male; Middle Aged; Nafarelin; Neoplasm Recurrence, Local; Prostate; Prostatic Neoplasms; Remission Induction; Time Factors | 1987 |